Antisense targeting of TGF-beta1 augments BMP-induced upregulation of osteopontin, type I collagen and Cbfa1 in human Saos-2 cells.

[1]  V. Salih,et al.  Shedding of a soluble form of BMP receptor-IB controls bone cell responses to BMP. , 2006, Bone.

[2]  K. Takaoka,et al.  Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2* , 2006, Journal of Biological Chemistry.

[3]  M. Rivas,et al.  Immunization with Murine Breast Cancer Cells Treated with Antisense Oligodeoxynucleotides to Type I Insulin-Like Growth Factor Receptor Induced an Antitumoral Effect Mediated by a CD8+ Response Involving Fas/Fas Ligand Cytotoxic Pathway1 , 2006, The Journal of Immunology.

[4]  Sophie Janssens,et al.  Transforming Growth Factor- 1 to the Bone , 2005 .

[5]  Jonas Larsson,et al.  The role of Smad signaling in hematopoiesis , 2005, Oncogene.

[6]  T. Nishihara,et al.  Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[7]  E. Stanley,et al.  Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice , 2004, Cancer Research.

[8]  R. Wiseman,et al.  Hypoxia suppresses runx2 independent of modeled microgravity , 2004, Journal of cellular physiology.

[9]  I. Frahm,et al.  Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity , 2004, Oncogene.

[10]  S. Bae,et al.  Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein , 2002, Oncogene.

[11]  Masaki Noda,et al.  Negative Regulation of Bone Morphogenetic Protein/Smad Signaling by Cas-interacting Zinc Finger Protein in Osteoblasts* , 2002, The Journal of Biological Chemistry.

[12]  A. Gressner,et al.  Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  Su‐Li Cheng,et al.  Signal Transductions Induced by Bone Morphogenetic Protein-2 and Transforming Growth Factor-β in Normal Human Osteoblastic Cells* , 2002, The Journal of Biological Chemistry.

[14]  Allan Balmain,et al.  TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.

[15]  R. Baron,et al.  Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. , 2001, Bone.

[16]  R. Derynck,et al.  TGF‐β‐induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation , 2001, The EMBO journal.

[17]  F. Lallemand,et al.  Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. , 2001, Bone.

[18]  J. Wozney,et al.  Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.

[19]  G. Tortora,et al.  Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  K. Miyazono,et al.  A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Stephen N. Jones,et al.  Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene , 2000, Journal of cellular physiology.

[22]  G. Karsenty.  The genetic transformation of bone biology. , 1999, Genes & development.

[23]  K. Miyazono,et al.  Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. , 1999, Molecular biology of the cell.

[24]  E. Nishida,et al.  Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-β-induced Gene Expression* , 1999, The Journal of Biological Chemistry.

[25]  M. Ferguson,et al.  Pathogenesis of cleft palate in TGF-beta3 knockout mice. , 1999, Development.

[26]  B. L. Riggs,et al.  Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein‐2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte Maturation , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Y. Lee,et al.  Inhibition of transforming growth factor-beta 2 expression with phosphorothioate antisense oligonucleotides in U937 cells. , 1999, Bioorganic & medicinal chemistry letters.

[28]  J. Wrana,et al.  Smad2 Overexpression Enhances Smad4 Gene Expression and Suppresses CBFA1 Gene Expression in Osteoblastic Osteosarcoma ROS17/2.8 Cells and Primary Rat Calvaria Cells* , 1998, The Journal of Biological Chemistry.

[29]  M. McKee,et al.  Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  P. Marie,et al.  The Effects of Fibroblast Growth Factor‐2 on Human Neonatal Calvaria Osteoblastic Cells Are Differentiation Stage Specific , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  K. Miyazono,et al.  Induction of Smad6 mRNA by bone morphogenetic proteins. , 1998, Biochemical and biophysical research communications.

[32]  T. Yoneda,et al.  Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12* , 1998, The Journal of Biological Chemistry.

[33]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[34]  G. Gross,et al.  Parathyroid Hormone Enhances Early and Suppresses Late Stages of Osteogenic and Chondrogenic Development in a BMP‐Dependent Mesenchymal Differentiation System (C3H10T½) , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  S. Rittling,et al.  Osteopontin expression in mammary gland development and tumorigenesis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[36]  A. Baldini,et al.  Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia , 1997, Nature Genetics.

[37]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[38]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[39]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[40]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[41]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[42]  L. Bonewald,et al.  Expression of Bone Morphogenetic Proteins by Osteoinductive and Non-osteoinductive Human Osteosarcoma Cells , 1996, Journal of dental research.

[43]  Subburaman Mohan,et al.  Growth factors for bone growth and repair: IGF, TGFβ and BMP , 1996 .

[44]  R. Derynck,et al.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype , 1996, The Journal of cell biology.

[45]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[46]  M. Gebhardt,et al.  Expression of transforming growth factor‐beta (TGF‐β) receptors, TGF‐β1 and TGF‐β2 production and autocrine growth control in osteosarcoma cells , 1994 .

[47]  L. Bonewald,et al.  Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term cultures of fetal rat calvarial osteoblasts , 1994 .

[48]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[49]  M. Hikida,et al.  The secondary antigen-specific IgE response in murine lymphocytes is resistant to blockade by anti-IL4 antibody and an antisense oligodeoxynucleotide for IL4 mRNA. , 1993, Cellular Immunology.

[50]  L. Bonewald,et al.  Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). , 1992, The Journal of biological chemistry.

[51]  E. Amento,et al.  Bone morphogenetic protein‐2b stimulation of growth and osteogenic phenotypes in rat osteoblast‐like cells: Comparison with TGF‐β1 , 1991 .

[52]  G. Stein,et al.  Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[54]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[55]  S. Salzano,et al.  Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Induces the Osteoblastic Differentiation of the Human Osteosarcoma Cell Line SaOS-2 , 2002, Calcified Tissue International.

[56]  D. M. Morgan,et al.  Tetrazolium (MTT) assay for cellular viability and activity. , 1998, Methods in molecular biology.

[57]  J. Ranchalis,et al.  Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration , 1994 .

[58]  J. Wergedal,et al.  Differentiation of normal human bone cells by transforming growth factor-beta and 1,25(OH)2 vitamin D3. , 1992, Metabolism: clinical and experimental.

[59]  W. Butler,et al.  The nature and significance of osteopontin. , 1989, Connective tissue research.